Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 12657

Winter Park, FL 32789


Study Summary:

Phase III study to assess the efficacy and safety of 52 weeks once daily treatment with orally inhaled tiotropium + olodaterol FDC (delivered by the RESPIMAT Inhaler) compared with the individual components ( tiotropium, olodaterol) (delivered by the RESPIMAT Inhaler) in patients with Chronic Obstructive Pulmonary Disease (COPD).


Qualified Participants Must:

• Have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
• Be 40 years of age or older.
• Be a current or ex-smoker


Qualified Participants May Receive:

Study related medication and care at no cost. Eligible participants will be compensated for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.